Cargando…
Pyruvate kinase activator: A major breakthrough in the world of Hematology
Pyruvate Kinase Deficiency (PKD) is a rare genetic disorder targeting Red Blood Cells that manifests as non-spherocytic hemolytic anemia. It has a global distribution with an unknown prevalence, and the frequently reported estimates for different geographical regions show a significant disparity. Be...
Autores principales: | Iqbal, Amna, Habiba, Ume, Waseem, Radeyah, Islam, Zarmina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577647/ https://www.ncbi.nlm.nih.gov/pubmed/36268365 http://dx.doi.org/10.1016/j.amsu.2022.104631 |
Ejemplares similares
-
Cat scratch disease in a 23-year-old male–Case report
por: Waseem, Radeyah, et al.
Publicado: (2023) -
“Do benzodiazepines have a future in treating acute vertigo"
por: Shahnoor, Syeda, et al.
Publicado: (2022) -
Treating pyruvate kinase deficiency with Mitapivat: a short communication
por: Larik, Muhammad Omar, et al.
Publicado: (2023) -
Real-World Effectiveness of Tixagevimab and Cilgavimab (Evusheld) in Patients With Hematological Malignancies
por: Ocon, Anthony J., et al.
Publicado: (2022) -
Dostarlimab: A breakthrough in the field of oncology
por: Hussain, Hassan ul, et al.
Publicado: (2022)